drugset / Trial / NCT01903070

Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment

NCT01903070

Phase 4 Completed 99 enrolled Profil Institute for Metabolic Research GmbH
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a bi-centric, prospective, open study comparing the effects of linagliptin on active GLP-1 concentrations in subjects with renal impairment compared to subjects with normal renal function.

Timeline

Start
2013-07-11
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Linagliptin Small molecule

Indications